Iovance: Less And Less Likely To Reap Reward From Its Pioneering Work
Iovance stock drops 90% despite historic approval for Amtagvi. Click here for a full investment analysis of IOVA stock.
Transgene Appoints Chief Technical Officer (CTO) to Power Future Innovations
Dr. Simone Steiner will focus on improving the manufacturing processes of individualized immunotherapies based onmyvac ® platform  Strasbourg, France, April 1, 2025, 5:45 p.m. CET — Transgene ...
John B. Sanfilippo & Son: Production Growth, Dividends, And Solid Financial Metrics - Is It ...
Discover why John B. Sanfilippo & Son might be an undervalued gem. Learn about its strong dividend yield, growth metrics, and ...